Panel Discussion: Future Direction of Analytical Capabilities for Better Vaccines

Time: 2:30 pm
day: Day Two


  • Are modified protein-based therapeutic assays enough for genetic vaccines, or are we in dire need of the development newer, more modern analytical tools?
  • What are the current gaps in analytical tools to ensure future success of genetic vaccines for infectious diseases and oncology indications?
  • Where will future innovation come from and how must regulation change to support newer techniques?